Study Highlights High Opioid Prescription Rates for Florida Women of Reproductive Age; Implications for Maternal and Infant Health

Why it matters locally: The national report on opioid prescriptions among women of reproductive age carries significant implications for Florida. With a large population of 22.6 million, and a substantial number of women in the 15-44 age range covered by Medicaid and private insurance, Florida is likely experiencing a similar prevalence of opioid prescriptions among this demographic. High rates of opioid use among these women can increase the risk of neonatal abstinence syndrome (NAS) in newborns – requiring specialized care and straining the state's healthcare resources. Furthermore, it highlights the need for increased focus on alternative pain management strategies and addiction prevention programs specifically tailored for women of reproductive age in Florida, potentially impacting allocations of state health funding.

---

A report in the Morbidity and Mortality Weekly Report (MMWR) has examined the prevalence of opioid painkiller prescriptions among women of reproductive age in the United States between 2008 and 2012. The Centers for Disease Control and Prevention (CDC) released the report. The study focused on women aged 15-44 who were enrolled in either Medicaid or had private insurance. Researchers analyzed prescription data to determine the percentage of women filling at least one opioid prescription each year during the five-year period. The findings indicated that a significant portion of women in this demographic received opioid prescriptions. The report stated that over one-third of reproductive-aged women enrolled in Medicaid filled an opioid painkiller prescription annually. Among women with private insurance, the rate was over one-quarter. The report does not offer reasons for the prescription rates, but it provides a quantification of opioid use among women during their reproductive years. Further research would need to be done to determine the conditions for which the opioids were prescribed, the dosages prescribed, and the long-term outcomes for the respective patients. The scope of the study was limited to the period from 2008 to 2012. Data on more recent trends in opioid prescriptions for this population would provide a more current understanding of the issue.